Trial intelligence / Profile preview

EMPIRE-Elafin in CABG surgery

2010-019527-58Phase 2Completed

Sponsor
NHS Lothian
Start
Apr 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2 trial of tiprelestat in myocardial ischemia-reperfusion injury and post-operative inflammation, sponsored by NHS Lothian. Started Apr 2011; status: completed.

02

Drugs

tiprelestat
03

Conditions

myocardial ischemia-reperfusion injurypost-operative inflammation

Beyond the preview

Go deeper on 2010-019527-58.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019527-58.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call